Evolution of the concept of immune dysregulation and current classification
- 18 October 2024
- journal article
- editorial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 155 (1) , 89-91
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K08AI135091)
- Burroughs Wellcome Fund
- Hartwell Foundation
This publication has 10 references indexed in Scilit:
- Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabBlood Advances, 2024
- The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of ImmunityJournal of Clinical Immunology, 2022
- Defining and targeting patterns of T cell dysfunction in inborn errors of immunityFrontiers in Immunology, 2022
- Genetics of Pediatric Immune-Mediated Diseases and Human ImmunityAnnual Review of Immunology, 2021
- Patterns of Immune Dysregulation in Primary Immunodeficiencies: A Systematic ReviewThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Primary immune regulatory disorders: a growing universe of immune dysregulationCurrent Opinion in Allergy and Clinical Immunology, 2020
- Human inborn errors of immunity: An expanding universeScience Immunology, 2020
- Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy‐candidiasis‐ectodermal dystrophyImmunological Reviews, 2018
- Human RAG mutations: biochemistry and clinical implicationsNature Reviews Immunology, 2016
- Morbidity and mortality in common variable immune deficiency over 4 decadesBlood, 2012